Aa
Aa
A
A
A
Close
333672 tn?1273792789

MS research notes from American Academy of Neurology meeting

http://www.acceleratedcure.org:8080/node/3205

(I hope this url lasts! After the standard wwwdot, it's acceleratedcure [.] org [:] 8080/node/3205)

This showed up in my blog reader the other week. It's pretty long, but there are some interesting tidbits so I thought maybe others might be interested.

One thing I thought was interesting was that someone tried to compare the results of a bunch of different clinical trials, but found it difficult because of variations like how the different studies defined a relapse (apparently, most of the later studies showed less relapses in part b/c relapses were defined more stringently). If the neuros can't agree on what a relapse is, how can we be expected to get it straight?

sho
2 Responses
Sort by: Helpful Oldest Newest
333672 tn?1273792789
This was another one I found very interesting, about the comparison of white matter and gray matter atrophy in MS:

A 4-Year Longitudinal Study of Gray Matter
Atrophy in Multiple Sclerosis Patients Elizabeth Fisher,
Jar-Chi Lee, Kunio Nakamura, Richard Rudick

This study found that atrophy rates increase with disease progression
(like the last study). WM atrophy happened at a fairly constant rate
over the progression of MS (CIS->RRMS->SPMS) at about 3X the
rate of controls. GM atrophy, however, accelerates with disease
progression going from about 3X to 8X to 14X the rate of
controls. They found a moderate correlation between GM atrophy and
EDSS. WM atrophy correlated with GM atrophy in RRMS, but not in
SPMS. They conclude that MS appears to be a predominantly GM disease.

This has big implications for how drugs are developed and approved
given our previous bias that it was strictly a WM disease.
Helpful - 0
230625 tn?1216761064
Thanks for posting this.  I'll have to go take a look.

I can understand your point on comparing results.  I would think that in clinical trials for a specific disease that there would be a published standard for defining the measuring criteria!!!   But, of course, this disease is so unpredictable and non-standard!

Take care, Pat :)
Helpful - 0
Have an Answer?

You are reading content posted in the Multiple Sclerosis Community

Top Neurology Answerers
987762 tn?1671273328
Australia
5265383 tn?1669040108
ON
1756321 tn?1547095325
Queensland, Australia
1780921 tn?1499301793
Queen Creek, AZ
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Popular Resources
Find out how beta-blocker eye drops show promising results for acute migraine relief.
In this special Missouri Medicine report, doctors examine advances in diagnosis and treatment of this devastating and costly neurodegenerative disease.
Here are 12 simple – and fun! – ways to boost your brainpower.
Discover some of the causes of dizziness and how to treat it.
Discover the common causes of headaches and how to treat headache pain.
Two of the largest studies on Alzheimer’s have yielded new clues about the disease